Antares Vision Group, a technological partner in the digitalisation of products and supply chains for companies and institutions, will introduce a new traceability solution for pharmaceutical bottles at Pack Expo, 3-6th November in Chicago.
Molex, parent company of Phillips Medisize, has announced that it has signed an agreement to purchase Vectura Group Limited, a leader in inhalation drug device design and formulation.
A peer reviewed study published in Frontiers in Neuroscience has shown that Ellorarxine, a novel drug compound developed by biotech spinout Nevrargenics, has shown a robust neuroprotective effect in cultured cells and reaches its target in animals.
DevCo Partners Ltd has announced a capital raise resulting in 616 MEUR of total commitments for its long-term single asset investment vehicle for Medix Biochemica.
The solution aims to efficiently capture cell-free DNA directly from bodily fluids to improve early disease detection, treatment monitoring, and personalised medicine.
Bayer is taking a step in the emerging healthy-ageing space by offering consumers new tools to help them support their healthy-ageing journey with its new Age Factor ecosystem.
Laura Vergani joins the international biopharmaceuticals group after working with big names including Walgreens Boots Alliance, Barclays, and Standard & Poor’s.
Renato Rjavec, ArisGlobal, discusses how generative AI (GenAI) technology is transforming everyday regulatory and safety processes, thanks to its ability to summarise key insights and findings from across huge, diverse bodies of content and data.
